Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Report Buyer Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Immunological and Biotherapy Cancer Treatments to Reach $42 billion in Sales by 2011 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report on the development of modern cancer therapies
Immunological and Biotherapy Cancer Treatments to Reach $42 billion in Sales by 2011

 

PRZOOM - /newswire/ - London, United Kingdom, 2007/07/14 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report on the development of modern cancer therapies.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The new report, “Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments” forecasts that there is likely to be a dramatic change over the next five years in treatment methods.

While traditional cancer therapies like chemotherapy and radiation currently account for the most common forms of medical care today, newer immunological and biotherapy treatments will soon take up a larger share of the market, reaching 46% or $42 billion in sales by 2011.

There have been several successful new treatments products launched in the past, including Rituxan, Herceptin, Gleevec and Avastin. Their success has set the stage for belief that newer products will thrive just as well from a business standpoint. There are nearly 80 cancer immunotherapy products in late stage development for various cancer treatments, and therapeutics like Gardisil and Dacogen which have been recently approved, are likely to contribute to a further upsurge in the market.

The immunotherapy/biotherapy cancer market has benefited from several highly successful products, but it also has room for growth. The industry was estimated at $14.6 billion dollars in 2006, which represented a 36.4 % increase from 2004 estimates. The report forecasts that the potential world market is expected to exceed $60 billion within the next ten years.

Newer therapies are gaining widespread acceptance across the world. They are particularly used to treat lymphoma and breast cancer, and have generated the most revenues from treatment in these two segments. Cervical, lung and multiple myelomas have only lately been benefiting from recent immunological therapies, and are expected to be at the forefront of treatment from immunological and biotherapies.

The study examines the global market for monoclonal antibodies, vaccines, interleukins and interferons, antisense oligonucleotides, and apoptosis or programmed cell death as well as other therapies used as cancer treatments.
The report also delineates the market shares for companies in the field, profiles key companies and their current products, has global data from across the world and forecasts to 2011 for sales of monoclonal antibodies,vaccines and other biotherapeutic treatments.

“Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments,” is available from Report Buyer. For more information, please visit the website.

Report Buyer product ID: KAL00018

About Report Buyer
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare. The website now carries over 28,000 business information products, including market reports, studies and books. Report Buyer is the intelligent way to buy market research making it an essential resource for executives and information buyers worldwide. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Immunological and Biotherapy Cancer Treatments to Reach $42 billion in Sales by 2011

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Urmila Doraswami 
+44 207 060 7474 press[.]reportbuyer.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Report Buyer Ltd / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today